Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Synbiotics Mixtures on Gut Microbiota Composition in Healthy Infants.
Regular non-hydrolysed cow's milk I
+ Regular non-hydrolysed cow's milk II
+ Regular non-hydrolysed cow's milk - control
Other Study
Summary
Study start date: May 1, 2013
Actual date on which the first participant was enrolled.This study is initiated to investigate the effect of infant formula with added specific synbiotics mixture on proportion of beneficial bacteria.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.290 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: Healthy term infants (gestational age ≥ 37 1/7 and ≤ 41 6/7 weeks) aged 46 - 65 days (inclusive) at entry into the study Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study) Parents' or legal guardian's written informed consent Exclusion Criteria: Exclusion criteria for run-in period (visit 1, screening) are: Being weaned before inclusion (introduction of any other foods other than formula or human milk) Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2 z-scores of the median WHO growth standards Medical condition for which a special diet other than standard (non hydrolised) cow's milk-based infant formula is required Known congenital diseases or malformations which could interfere with the study (e.g. gastrointestinal malformations, congenital immunodeficiency), as per investigator's clinical judgement Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks prior to entry into the study Received Inactivated Poliovirus Vaccine (IPV) or Rotavirus Vaccine (RV) prior to entry into the study Gastroenteritis or diarrhoea in the last two weeks prior to entry into the study Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.4 intervention groups are designated in this study
25% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorGroup III
PlaceboGroup IV
No InterventionStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
King Chulalongkorn Memorial Hospital
Bangkok, ThailandPhramongkutklao Hospital
Bangkok, Thailand